Skip to content

Effect of Platelet rich plasma on shoulder pain

To evaluate the effect of platelet rich plasma on shoulder pain and disability index in patients of rotator cuff tear: an observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080140
Enrollment
30
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M668- Spontaneous rupture of other tendons

Interventions

Intervention1: PRP in patients with shoulder rotator cuff tear: under ultrasound guidance platelet concentrate 5-8 ml will be injected in the area of partial tear of muscles of rotator cuff tear/tendi

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Partial rotator cuff tear Visual analogue scale score of more than 3 for more than 3 months Patients who can understand and read Hindi and English

Exclusion criteria

Exclusion criteria: 1. History of previous surgery of shoulder joint 2. Complete tear of rotator cuff muscles with complete atrophy 3. Uncontrolled systemic disease 4. Known hypersensitivity to any of the local anaesthetics drug under study 5. History of any platelet or coagulation related disease 6. Red Flag signs : fracture, fever, malignancy, infection, unexplained weight loss, numbness/weakness of upper limb, night sweats 7. Patients with human immunodeficiency virus (HIV,) hepatitis C virus (HCV) and hepatitis B virus (HBsAg)

Design outcomes

Primary

MeasureTime frame
To compare the effect of platelet rich plasma (PRP) difference on shoulder pain and disability index (SPADI)Timepoint: 2 weeks, 1 month, 2 month, 3 month and 6 months

Secondary

MeasureTime frame
1. change in analgesic requirement 2. change in range of shoulder movement 3. patient satisfaction score and platelet count 4. any side effectsTimepoint: 1.Baseline, 1 month, 2 month, 3 months, 6 months 2.Baseline, 1 month, 2 month, 3 months, 6 months 3. 3 months , 6 months 4. Baseline, 1 month, 2 month, 3 months, 6 months

Countries

India

Contacts

Public ContactVanita Ahuja

Department of Anaesthesia and Intensive Care

vanitaanupam@gmail.com9646121649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026